| Followers | 202 |
| Posts | 25627 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Wednesday, November 16, 2022 12:41:02 PM
Give it a break. Most of the market I am looking at in bios is down. The price has been fluctuating and has not been down 5% all day, it has been recovering for the day and is still up 34.11% for the month (at the moment I checked, just as I posted this) with the presentation at SNO yet to come and probably more news.
Some swing traders want this to go down so they can buy. That's the ridiculousness of it. Some traders missed their chance to get in as much as they wanted early because they were likely trading elsewhere and now they are annoyed they can't get their dollars back in as cheaply and can't get as many shares as they owned previously. Tough luck. It went up more rapidly than some were expecting. It happens. You can tell when certain longs can't say anything nice.
The market maker was likely taken by surprise and is delivering without shares and likely needs this to go down to break even. So pushing it down, continuing to supply despite no shares (going short), and hoping the volume subsides is probably the best they can do. They have to cover in 3 trading days. They can roll it over though, assuming no more volume rushes in. And that 9 million was a lot. So they may need a real push to get this lower, it's not .14 anymore. It costs real money to be wrong.
Some swing traders want this to go down so they can buy. That's the ridiculousness of it. Some traders missed their chance to get in as much as they wanted early because they were likely trading elsewhere and now they are annoyed they can't get their dollars back in as cheaply and can't get as many shares as they owned previously. Tough luck. It went up more rapidly than some were expecting. It happens. You can tell when certain longs can't say anything nice.
The market maker was likely taken by surprise and is delivering without shares and likely needs this to go down to break even. So pushing it down, continuing to supply despite no shares (going short), and hoping the volume subsides is probably the best they can do. They have to cover in 3 trading days. They can roll it over though, assuming no more volume rushes in. And that 9 million was a lot. So they may need a real push to get this lower, it's not .14 anymore. It costs real money to be wrong.
I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
